EUVIMEDScopri EUVIMED
BeobachtungsstudieMultizentrische StudieOpen access

The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort

Rebekah J Nevel, Gail H Deutsch, Daniel Craven, Robin Deterding, Martha P Fishman, Jennifer A Wambach, Alicia Casey, Katie Krone, Deborah R Liptzin, Michael G O'Connor, Geoffrey Kurland, Jane B Taylor and 24 more

Pediatric Pulmonology · 2024-09 · 59 (9) · 2236-2246

DOI: 10.1002/ppul.26568 ↗

At a glance

Beobachtungsstudie in Pediatric Pulmonology, published online on 2023-07-04. Written by Rebekah J Nevel and 35 co-authors. Institution: Department of Child Health, Pediatric Pulmonary Medicine, University of Missouri Children's Hospital, Columbia, Missouri, USA. Major MEDLINE topics: Registries, Lung Diseases, Interstitial. Cited 33 times so far (Crossref); 21 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Introduction

Childhood interstitial and diffuse lung disease (chILD) encompasses a broad spectrum of rare disorders. The Children's Interstitial and Diffuse Lung Disease Research Network (chILDRN) established a prospective registry to advance knowledge regarding etiology, phenotype, natural history, and management of these disorders.

Methods

This longitudinal, observational, multicenter registry utilizes single‐IRB reliance agreements, with participation from 25 chILDRN centers across the U.S. Clinical data are collected and managed using the Research Electronic Data Capture (REDCap) electronic data platform.

Results

We report the study design and selected elements of the initial Registry enrollment cohort, which includes 683 subjects with a broad range of chILD diagnoses. The most common diagnosis reported was neuroendocrine cell hyperplasia of infancy, with 155 (23%) subjects. Components of underlying disease biology were identified by enrolling sites, with cohorts of interstitial fibrosis, immune dysregulation, and airway disease being most commonly reported. Prominent morbidities affecting enrolled children included home supplemental oxygen use (63%) and failure to thrive (46%).

Conclusion

This Registry is the largest longitudinal chILD cohort in the United States to date, providing a powerful framework for collaborating centers committed to improving the understanding and treatment of these rare disorders.

Subjects

MeSH terms (MEDLINE)

RegistriesLung Diseases, InterstitialHumansChildUnited StatesMaleFemaleChild, PreschoolInfantLongitudinal StudiesAdolescentResearch DesignProspective StudiesCohort Studies

Author keywords

NEHIinterstitial lung diseaserare lung disease

Authors and institutions

  • Department of Child Health, Pediatric Pulmonary Medicine, University of Missouri Children's Hospital, Columbia, Missouri, USA.
  • Department of Laboratory Medicine and Pathology, Seattle Children's Hospital, University of Washington Medical Center, Seattle, Washington, USA.
  • Pediatric Pulmonology, Rainbow Babies & Children's Hospital, Case School of Medicine, Cleveland, Ohio, USA.
  • Section of Pediatric Pulmonology, Department of Pediatrics, University of Colorado School of Medicine, Children's Hospital of Colorado, Aurora, Colorado, USA.
  • Division of Pulmonary Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Edward Mallinckrodt Department of Pediatrics, Division of Newborn Medicine, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri, USA.

Funding

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Cite

APA

Nevel, R. J., Deutsch, G. H., Craven, D., Deterding, R., Fishman, M. P., Wambach, J. A., Casey, A., Krone, K., Liptzin, D. R., O'Connor, M. G., Kurland, G., Taylor, J. B., Gower, W. A., Hagood, J. S., Conrad, C., Tam-Williams, J. B., Fiorino, E. K., Goldfarb, S., Sadreameli, S. C., …, & chILD Registry Collaborative (2024). The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort. Pediatric Pulmonology, 59(9), 2236-2246. https://doi.org/10.1002/ppul.26568

Vancouver

Nevel RJ, Deutsch GH, Craven D, Deterding R, Fishman MP, Wambach JA, et al. The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort. Pediatric Pulmonology. 2024;59(9):2236-2246. doi:10.1002/ppul.26568

BibTeX
@article{Nevel2024,
  author = {Nevel, Rebekah J and Deutsch, Gail H and Craven, Daniel and Deterding, Robin and Fishman, Martha P and Wambach, Jennifer A and Casey, Alicia and Krone, Katie and Liptzin, Deborah R and O'Connor, Michael G and Kurland, Geoffrey and Taylor, Jane B and Gower, William A and Hagood, James S and Conrad, Carol and Tam-Williams, Jade B and Fiorino, Elizabeth K and Goldfarb, Samuel and Sadreameli, Sara C and Nogee, Lawrence M and Montgomery, Gregory and Hamvas, Aaron and Laguna, Theresa A and Bansal, Manvi and Lew, Cheryl and Santiago, Maria and Popova, Antonia and De, Aliva and Chan, Marilynn and Powers, Michael R and Josephson, Maureen B and Camburn, Devaney and Voss, Laura and Li, Yun and Young, Lisa R and chILD Registry Collaborative, chILD Registry Collaborative},
  title = {The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort},
  journal = {Pediatric Pulmonology},
  year = {2024},
  volume = {59},
  number = {9},
  pages = {2236--2246},
  doi = {10.1002/ppul.26568}
}
Start for free →